Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2011 1
2012 1
2013 1
2015 1
2017 3
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between early administration of abciximab and TIMI flow in STEMI patients undergoing primary angioplasty: findings from a large regional STEMI network.
Izzo A, Rosiello R, Lucchini G, Tomasi L, Mantovani P, Lettieri C, Baccaglioni N, Romano M, Buffoli F, Izzo B, Zanini R. Izzo A, et al. Among authors: rosiello r. J Cardiovasc Med (Hagerstown). 2017 Jun;18(6):398-403. doi: 10.2459/JCM.0000000000000426. J Cardiovasc Med (Hagerstown). 2017. PMID: 27454650
[A novel standard protocol of long-term follow-up shared with general practitioners after percutaneous coronary intervention: appropriateness and economic impact].
Lettieri C, Colombo P, Rosiello R, Morici N, Parogni P, Musumeci G, Tabaglio E, Zadra A, Cattaneo MG, Soriano F, Galavotti M, Klugmann S, Senni M, Valsecchi O, Zanini R, Rossini R. Lettieri C, et al. Among authors: rosiello r. G Ital Cardiol (Rome). 2015 Oct;16(10):565-73. doi: 10.1714/2028.22042. G Ital Cardiol (Rome). 2015. PMID: 26444215 Italian.
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).
Ribichini F, Romano M, Rosiello R, La Vecchia L, Cabianca E, Caramanno G, Milazzo D, Loschiavo P, Rigattieri S, Musarò S, Pironi B, Fiscella A, Amico F, Indolfi C, Spaccarotella C, Bartorelli A, Trabattoni D, Della Rovere F, Rolandi A, Beqaraj F, Belli R, Sangiorgio P, Villani R, Berni A, Sheiban I, Lopera Quijada MJ, Cappi B, Ribaldi L, Vassanelli C; EXECUTIVE Trial Investigators. Ribichini F, et al. Among authors: rosiello r. JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18. JACC Cardiovasc Interv. 2013. PMID: 24055444 Free article. Clinical Trial.